Nikolay V. Petrovsky

Nikolay V. Petrovsky

Auto-generated profile, based on publicly available information

Nikolay V. Petrovsky

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2018 in Urologiia
Verified
Journal Article
Closed access
PGP.V. Glybochko Glybochko
P.V. Glybochko Glybochko
YAYu.G. Alyaev Alyaev
Yu.G. Alyaev Alyaev
AAA.V. Amosov Amosov
A.V. Amosov Amosov
DED.V. Enikeev Enikeev
D.V. Enikeev Enikeev
DCD.V. Chinenov Chinenov
D.V. Chinenov Chinenov
YCYa.N. Chernov Chernov
Ya.N. Chernov Chernov
Prostate cancer is one of the most common types of cancer in men. The gold standard for the detection of prostate cancer is ultrasound guided transrectal prostate biopsy. The detectability of cancer using this method is from 30 to 50%. As a result, many men undergo multiple repeat biopsies for suspected prostate cancer. The European Association of Urology does not give any recommendations on this matter. A revolutionary new method in the diagnosis of prostate cancer is a targeted prostate biopsy using a fusion of multiparametric magnetic resonance imaging (MRI) and ultrasound. At the R.M. Fronstein Clinic of Urology, 55 patients with suspected prostate cancer from September 2017 to January 2018 underwent fusion prostate biopsy. Of them, 21 patients had negative primary biopsies. Two patients had verified prostate cancer. 32 patients did not undergo primary biopsies. The findings of the study suggest that using MRI-ultrasound fusion for guidance of targeted prostate biopsy improves the quality of the histological material, allows patients to avoid unnecessary biopsy, reduces the number of punctures, thereby offering higher diagnostic performance in detecting prostate cancer. MRI-ultrasound fusion targeted biopsy has a high sensitivity in detecting clinically significant cancer and low for clinically insignificant cancers. The technique affords accurate detection of the location and extent of pathological lesions in the prostate thus allowing focal therapy for prostate cancer.



15 January 2025 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
DID. G. Ioseliani
D. G. Ioseliani
AKA. G. Koledinskiy
A. G. Koledinskiy
SSS. P. Semitko
S. P. Semitko
LRL. M. Rapoport
L. M. Rapoport
DAD. A. Asadov
D. A. Asadov
PGP. V. Glybochko
P. V. Glybochko
According to the Russian Society of Urologists, almost half of the male population of the country aged 27 to 77 suffers from erectile dysfunction (ED). ED should be considered not only as a serious medical nosology, but also as an important socio-psychological problem of national importance due to its demographic significance. There are many methods of treating ED, including drug therapy and penile prosthetics, as well as certain psychotherapeutic measures. The world's experience in combating this disease allows us to assert that an important condition for determining the correct approach to treating ED is an accurate diagnosis of the causes of ED. Among the many causes of ED, vascular causes are quite common. Given the rapid development of endovascular and low-traumatic approaches to vascular pathology, the method of improving the inflow and obstructing the outflow in vasculogenic ED is becoming increasingly obvious and effective. The presented article discusses a clinical case of successful endovascular complex treatment of recurrent venocorporeal ED in a young patient.